COPD Therapeutics in Major Developed Markets Forecast to year 2021: 1 | Page 6

6.2 Co-development Deals 85
6.2.1 Theravance Enters into Development and Commercialization Agreement with Mylan 90
6.2.2 Five Prime Therapeutics Expands Co-Development Agreement with GSK 90
6.2.3 Galapagos Enters into Strategic Alliance with Roche 91
6.2.4 Forest Laboratories Enters into Agreement with Almirall 91
6.2.5 Forest Laboratories Enters into Co-Development Agreement with Nycomed 91
7 Appendix 92
7.1 All Pipeline Drugs by Phase 92
7.1.1 Discovery 92
7.1.2 Preclinical 94
7.1.3 Phase I 99
7.1.4 Phase II 101
7.1.5 Phase III 104
7.1.6 Filed 106
7.2 Market Forecasts to 2021 106
7.2.1 Global 106
7.2.2 US 106
7.2.3 Canada 107
7.2.4 UK 107
7.2.5 France 108
7.2.6 Germany 108
7.2.7 Italy 109
7.2.8 Spain 109
7.2.9 Japan 110
7.3 Bibiography 110